Avantor (AVTR) Income from Continuing Operations (2018 - 2026)
Avantor (AVTR) posted quarterly Income from Continuing Operations of 38100000.0 for Q2 2026, down 41.11% year-over-year from 64700000.0 in Q2 2025, and down 12.01% quarter-over-quarter from 43300000.0 in Q1 2026.
Avantor (AVTR) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Avantor's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 38100000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 41.11% year-over-year to 38100000.0; the TTM figure through Jun 2026 stood at 578000000.0 (down 184.08% YoY), while the FY2025 annual figure was 530200000.0, down 174.52% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 38100000.0, down from 43300000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 500400000.0 in Q4 2024, with the low at 711800000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 78800000.0 (2024), against an average of 70572222.22.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations surged 1372.6% in 2024, then tumbled 1331.49% in 2025.
- Avantor's Income from Continuing Operations stood at 141700000.0 in 2022, then slumped by 30.49% to 98500000.0 in 2023, then jumped by 408.02% to 500400000.0 in 2024, then sank by 89.53% to 52400000.0 in 2025, then dropped by 27.29% to 38100000.0 in 2026.
- Business Quant data shows AVTR's Income from Continuing Operations at 38100000.0 in Q2 2026, 43300000.0 in Q1 2026, and 52400000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Avantor | 9.62 Bn | 9.31 Bn | 537.00 Mn | 38.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.10 Mn |
| Mar 31, 2026 | 43.30 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Sep 30, 2025 | -711.80 Mn |
| Jun 30, 2025 | 64.70 Mn |
| Mar 31, 2025 | 64.50 Mn |
| Dec 31, 2024 | 500.40 Mn |
| Sep 30, 2024 | 57.80 Mn |
| Jun 30, 2024 | 92.90 Mn |
| Mar 31, 2024 | 60.40 Mn |
| Dec 31, 2023 | 98.50 Mn |
| Sep 30, 2023 | 108.40 Mn |
| Jun 30, 2023 | -7.30 Mn |
| Mar 31, 2023 | 121.50 Mn |
| Dec 31, 2022 | 141.70 Mn |
| Sep 30, 2022 | 167.00 Mn |
| Jun 30, 2022 | 187.40 Mn |
| Mar 31, 2022 | 190.40 Mn |
| Dec 31, 2021 | 94.00 Mn |
| Sep 30, 2021 | 156.80 Mn |